Pharmacodynamic Biomarkers Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Exposure Biomarkers
1.2.3 Effect Biomarkers
1.2.4 Susceptibility Biomarkers
1.3 Market by Application
1.3.1 Global Pharmacodynamic (PD) Biomarkers Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmacodynamic (PD) Biomarkers Market Perspective (2017-2028)
2.2 Pharmacodynamic (PD) Biomarkers Growth Trends by Region
2.2.1 Pharmacodynamic (PD) Biomarkers Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmacodynamic (PD) Biomarkers Historic Market Size by Region (2017-2022)
2.2.3 Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Region (2023-2028)
2.3 Pharmacodynamic (PD) Biomarkers Market Dynamics
2.3.1 Pharmacodynamic (PD) Biomarkers Industry Trends
2.3.2 Pharmacodynamic (PD) Biomarkers Market Drivers
2.3.3 Pharmacodynamic (PD) Biomarkers Market Challenges
2.3.4 Pharmacodynamic (PD) Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacodynamic (PD) Biomarkers Players by Revenue
3.1.1 Global Top Pharmacodynamic (PD) Biomarkers Players by Revenue (2017-2022)
3.1.2 Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Players (2017-2022)
3.2 Global Pharmacodynamic (PD) Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacodynamic (PD) Biomarkers Revenue
3.4 Global Pharmacodynamic (PD) Biomarkers Market Concentration Ratio
3.4.1 Global Pharmacodynamic (PD) Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacodynamic (PD) Biomarkers Revenue in 2021
3.5 Pharmacodynamic (PD) Biomarkers Key Players Head office and Area Served
3.6 Key Players Pharmacodynamic (PD) Biomarkers Product Solution and Service
3.7 Date of Enter into Pharmacodynamic (PD) Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacodynamic (PD) Biomarkers Breakdown Data by Type
4.1 Global Pharmacodynamic (PD) Biomarkers Historic Market Size by Type (2017-2022)
4.2 Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Type (2023-2028)
5 Pharmacodynamic (PD) Biomarkers Breakdown Data by Application
5.1 Global Pharmacodynamic (PD) Biomarkers Historic Market Size by Application (2017-2022)
5.2 Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
6.2 North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
6.3 North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
7.2 Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
7.3 Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
8.2 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
8.3 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
9.2 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
9.3 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size (2017-2028)
10.2 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022)
10.3 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Pharmacodynamic (PD) Biomarkers Introduction
11.2.4 Merck Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.2.5 Merck Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Introduction
11.3.4 Bio-Rad Laboratories Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Detail
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Pharmacodynamic (PD) Biomarkers Introduction
11.4.4 QIAGEN Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.4.5 QIAGEN Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Pharmacodynamic (PD) Biomarkers Introduction
11.5.4 Roche Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.5.5 Roche Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Detail
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Pharmacodynamic (PD) Biomarkers Introduction
11.6.4 Danaher Corporation Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.6.5 Danaher Corporation Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Detail
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Pharmacodynamic (PD) Biomarkers Introduction
11.7.4 Siemens Healthcare Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.7.5 Siemens Healthcare Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Pharmacodynamic (PD) Biomarkers Introduction
11.8.4 Abbott Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.8.5 Abbott Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Detail
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Pharmacodynamic (PD) Biomarkers Introduction
11.9.4 Agilent Technologies Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
11.9.5 Agilent Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pharmacodynamic (PD) Biomarkers Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Exposure Biomarkers
Table 3. Key Players of Effect Biomarkers
Table 4. Key Players of Susceptibility Biomarkers
Table 5. Global Pharmacodynamic (PD) Biomarkers Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Pharmacodynamic (PD) Biomarkers Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Pharmacodynamic (PD) Biomarkers Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Pharmacodynamic (PD) Biomarkers Market Share by Region (2017-2022)
Table 9. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Pharmacodynamic (PD) Biomarkers Market Share by Region (2023-2028)
Table 11. Pharmacodynamic (PD) Biomarkers Market Trends
Table 12. Pharmacodynamic (PD) Biomarkers Market Drivers
Table 13. Pharmacodynamic (PD) Biomarkers Market Challenges
Table 14. Pharmacodynamic (PD) Biomarkers Market Restraints
Table 15. Global Pharmacodynamic (PD) Biomarkers Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Pharmacodynamic (PD) Biomarkers Market Share by Players (2017-2022)
Table 17. Global Top Pharmacodynamic (PD) Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacodynamic (PD) Biomarkers as of 2021)
Table 18. Ranking of Global Top Pharmacodynamic (PD) Biomarkers Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Pharmacodynamic (PD) Biomarkers Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pharmacodynamic (PD) Biomarkers Product Solution and Service
Table 22. Date of Enter into Pharmacodynamic (PD) Biomarkers Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmacodynamic (PD) Biomarkers Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2017-2022)
Table 26. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2023-2028)
Table 28. Global Pharmacodynamic (PD) Biomarkers Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Application (2017-2022)
Table 30. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Application (2023-2028)
Table 32. North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2023-2028) & (US$ Million)
Table 42. Thermo Fisher Scientific Company Detail
Table 43. Thermo Fisher Scientific Business Overview
Table 44. Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Product
Table 45. Thermo Fisher Scientific Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 46. Thermo Fisher Scientific Recent Development
Table 47. Merck Company Detail
Table 48. Merck Business Overview
Table 49. Merck Pharmacodynamic (PD) Biomarkers Product
Table 50. Merck Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 51. Merck Recent Development
Table 52. Bio-Rad Laboratories Company Detail
Table 53. Bio-Rad Laboratories Business Overview
Table 54. Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Product
Table 55. Bio-Rad Laboratories Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 56. Bio-Rad Laboratories Recent Development
Table 57. QIAGEN Company Detail
Table 58. QIAGEN Business Overview
Table 59. QIAGEN Pharmacodynamic (PD) Biomarkers Product
Table 60. QIAGEN Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 61. QIAGEN Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Pharmacodynamic (PD) Biomarkers Product
Table 65. Roche Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Danaher Corporation Company Detail
Table 68. Danaher Corporation Business Overview
Table 69. Danaher Corporation Pharmacodynamic (PD) Biomarkers Product
Table 70. Danaher Corporation Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 71. Danaher Corporation Recent Development
Table 72. Siemens Healthcare Company Detail
Table 73. Siemens Healthcare Business Overview
Table 74. Siemens Healthcare Pharmacodynamic (PD) Biomarkers Product
Table 75. Siemens Healthcare Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 76. Siemens Healthcare Recent Development
Table 77. Abbott Company Detail
Table 78. Abbott Business Overview
Table 79. Abbott Pharmacodynamic (PD) Biomarkers Product
Table 80. Abbott Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 81. Abbott Recent Development
Table 82. Agilent Technologies Company Detail
Table 83. Agilent Technologies Business Overview
Table 84. Agilent Technologies Pharmacodynamic (PD) Biomarkers Product
Table 85. Agilent Technologies Revenue in Pharmacodynamic (PD) Biomarkers Business (2017-2022) & (US$ Million)
Table 86. Agilent Technologies Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacodynamic (PD) Biomarkers Market Share by Type: 2021 VS 2028
Figure 2. Exposure Biomarkers Features
Figure 3. Effect Biomarkers Features
Figure 4. Susceptibility Biomarkers Features
Figure 5. Global Pharmacodynamic (PD) Biomarkers Market Share by Application in 2021 & 2028
Figure 6. Diagnostics Case Studies
Figure 7. Drug Discovery Case Studies
Figure 8. Personalized Medicine Case Studies
Figure 9. Others Case Studies
Figure 10. Pharmacodynamic (PD) Biomarkers Report Years Considered
Figure 11. Global Pharmacodynamic (PD) Biomarkers Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Pharmacodynamic (PD) Biomarkers Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pharmacodynamic (PD) Biomarkers Market Share by Region: 2021 VS 2028
Figure 14. Global Pharmacodynamic (PD) Biomarkers Market Share by Players in 2021
Figure 15. Global Top Pharmacodynamic (PD) Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacodynamic (PD) Biomarkers as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Pharmacodynamic (PD) Biomarkers Revenue in 2021
Figure 17. North America Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Pharmacodynamic (PD) Biomarkers Market Share by Country (2017-2028)
Figure 19. United States Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Pharmacodynamic (PD) Biomarkers Market Share by Country (2017-2028)
Figure 23. Germany Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Share by Region (2017-2028)
Figure 31. China Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Pharmacodynamic (PD) Biomarkers Market Share by Country (2017-2028)
Figure 39. Mexico Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Share by Country (2017-2028)
Figure 43. Turkey Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Pharmacodynamic (PD) Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 46. Merck Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 47. Bio-Rad Laboratories Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 48. QIAGEN Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 49. Roche Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 50. Danaher Corporation Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 51. Siemens Healthcare Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 52. Abbott Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 53. Agilent Technologies Revenue Growth Rate in Pharmacodynamic (PD) Biomarkers Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Industry Market Size
